208 related articles for article (PubMed ID: 32228724)
21. Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment.
Chamberlain MC; Glantz M; Groves MD; Wilson WH
Semin Oncol; 2009 Aug; 36(4 Suppl 2):S35-45. PubMed ID: 19660682
[TBL] [Abstract][Full Text] [Related]
22. Cerebrospinal fluid beta-2-microglobulin in adult patients with acute leukemia or lymphoma: a useful marker in early diagnosis and monitoring of CNS-involvement.
Hansen PB; Kjeldsen L; Dalhoff K; Olesen B
Acta Neurol Scand; 1992 Mar; 85(3):224-7. PubMed ID: 1575009
[TBL] [Abstract][Full Text] [Related]
23. The MRZ reaction and a quantitative intrathecal IgG synthesis may be helpful to differentiate between primary central nervous system lymphoma and multiple sclerosis.
Hottenrott T; Schorb E; Fritsch K; Dersch R; Berger B; Huzly D; Rauer S; Tebartz van Elst L; Endres D; Stich O
J Neurol; 2018 May; 265(5):1106-1114. PubMed ID: 29511863
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic value of interleukin-10 in cerebrospinal fluid for diffuse large B-cell lymphoma of the central nervous system.
Sasagawa Y; Akai T; Tachibana O; Iizuka H
J Neurooncol; 2015 Jan; 121(1):177-83. PubMed ID: 25258254
[TBL] [Abstract][Full Text] [Related]
25. CSF analysis for protein biomarker identification in patients with leptomeningeal metastases from CNS lymphoma.
Galicia N; Dégano R; Díez P; González-González M; Góngora R; Ibarrola N; Fuentes M
Expert Rev Proteomics; 2017 Apr; 14(4):363-372. PubMed ID: 28293970
[TBL] [Abstract][Full Text] [Related]
26. Enhanced detection of malignant lymphoma in cerebrospinal fluid by multiparameter flow cytometry.
Finn WG; Peterson LC; James C; Goolsby CL
Am J Clin Pathol; 1998 Sep; 110(3):341-6. PubMed ID: 9728609
[TBL] [Abstract][Full Text] [Related]
27. Flow cytometry as a diagnostic tool in lymphomatous or leukemic meningitis: ready for prime time?
Ahluwalia MS; Wallace PK; Peereboom DM
Cancer; 2012 Apr; 118(7):1747-53. PubMed ID: 22025088
[TBL] [Abstract][Full Text] [Related]
28. Flow cytometric analysis of cerebrospinal fluid has low diagnostic yield in samples without atypical morphology or prior history of hematologic malignancy.
Collie AM; Hill BT; Stevens GH; Fenner K; Gazdick E; Hsi ED
Am J Clin Pathol; 2014 Apr; 141(4):515-21. PubMed ID: 24619752
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of cerebrospinal fluid EBV-DNA and IL-10 as markers for in vivo diagnosis of AIDS-related primary central nervous system lymphoma.
De Luca A; Antinori A; Cingolani A; Larocca LM; Linzalone A; Ammassari A; Scerrati M; Roselli R; Tamburrini E; Ortona L
Br J Haematol; 1995 Aug; 90(4):844-9. PubMed ID: 7669663
[TBL] [Abstract][Full Text] [Related]
30. CXCL13 and CXCL12 in central nervous system lymphoma patients.
Fischer L; Korfel A; Pfeiffer S; Kiewe P; Volk HD; Cakiroglu H; Widmann T; Thiel E
Clin Cancer Res; 2009 Oct; 15(19):5968-73. PubMed ID: 19773382
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic utility of CSF soluble CD27 for primary central nervous system lymphoma in immunocompetent patients.
Murase S; Saio M; Andoh H; Takenaka K; Shinoda J; Nishimura Y; Sakai N; Takami T
Neurol Res; 2000 Jul; 22(5):434-42. PubMed ID: 10935213
[TBL] [Abstract][Full Text] [Related]
32. Clinical relevance of flow cytometric immunophenotyping of the cerebrospinal fluid in patients with diffuse large B-cell lymphoma.
Alvarez R; Dupuis J; Plonquet A; Christov C; Copie-Bergman C; Hemery F; Gaillard I; El Gnaoui T; Kuhnowski F; Bedoui M; Belhadj K; Brugières P; Haioun C
Ann Oncol; 2012 May; 23(5):1274-1279. PubMed ID: 21965472
[TBL] [Abstract][Full Text] [Related]
33. How to facilitate early diagnosis of CNS involvement in malignant lymphoma.
Korfel A; Nowosielski M; Pardo-Moreno J; Penalver FJ; Buda G; Bennani H; Costopoulos M; Le Garff-Tavernier M; Soussain C; Schmid M; Orfao JA; Glantz M
Expert Rev Hematol; 2016 Nov; 9(11):1081-1091. PubMed ID: 27677656
[TBL] [Abstract][Full Text] [Related]
34. Cerebrospinal fluid involvement in mantle cell lymphoma.
Valdez R; Kroft SH; Ross CW; Schnitzer B; Singleton TP; Peterson LC; Finn WG
Mod Pathol; 2002 Oct; 15(10):1073-9. PubMed ID: 12379754
[TBL] [Abstract][Full Text] [Related]
35. Diagnosis of acute leukemia in cerebrospinal fluid (CSF-acute leukemia).
Crespo-Solis E; López-Karpovitch X; Higuera J; Vega-Ramos B
Curr Oncol Rep; 2012 Oct; 14(5):369-78. PubMed ID: 22639108
[TBL] [Abstract][Full Text] [Related]
36. Multi-marker algorithms based on CXCL13, IL-10, sIL-2 receptor, and β2-microglobulin in cerebrospinal fluid to diagnose CNS lymphoma.
Maeyama M; Sasayama T; Tanaka K; Nakamizo S; Tanaka H; Nishihara M; Fujita Y; Sekiguchi K; Kohta M; Mizukawa K; Hirose T; Itoh T; Kohmura E
Cancer Med; 2020 Jun; 9(12):4114-4125. PubMed ID: 32314548
[TBL] [Abstract][Full Text] [Related]
37. Optimization of CSF biological investigations for CNS lymphoma diagnosis.
Armand M; Costopoulos M; Osman J; Tarfi S; Houillier C; Choquet S; Agnelo H; Bonnemye P; Ronez E; Settegrana C; Soussain C; Hoang-Xuan K; Le Garff-Tavernier M; Davi F
Am J Hematol; 2019 Oct; 94(10):1123-1131. PubMed ID: 31328307
[TBL] [Abstract][Full Text] [Related]
38. CSF flow cytometry greatly improves diagnostic accuracy in CNS hematologic malignancies.
Bromberg JE; Breems DA; Kraan J; Bikker G; van der Holt B; Smitt PS; van den Bent MJ; van't Veer M; Gratama JW
Neurology; 2007 May; 68(20):1674-9. PubMed ID: 17502548
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic strategies to investigate cerebrospinal fluid involvement in haematological malignancies.
Galati D; Di Noto R; Del Vecchio L
Leuk Res; 2013 Mar; 37(3):231-7. PubMed ID: 23287431
[TBL] [Abstract][Full Text] [Related]
40. Higher levels of progranulin in cerebrospinal fluid of patients with lymphoma and carcinoma with CNS metastasis.
Kimura A; Takemura M; Serrero G; Yoshikura N; Hayashi Y; Saito K; Inuzuka T
J Neurooncol; 2018 May; 137(3):455-462. PubMed ID: 29340960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]